Evaluation of fatty acid• -oxidation in patients with prior myocardial infarction in relation to myocardial blood flow, total oxidative metabolism, and left ventricular wall motion

Circulation Journal

Volumn 69, Issue 12, 2005, Pages 1459-1465

  Miyabe, Hiromichi ^a   Ohte, Nobuyuki ^a   Iida, Akihiko ^b   Narita, Hitomi ^b   Yoshida, Takayuki ^a   Kimura, Genjiro ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b Nagoya City Rehabilitation and Sports Center   (Japan)

Author keywords

Acetate; Metabolism; Myocardial infarction; Palmitate; PET

Indexed keywords

FATTY ACID;

ADULT; AEROBIC METABOLISM; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORONARY REPERFUSION; EVALUATION; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HUMAN; MALE; OXIDATION;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CORONARY CIRCULATION; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; OXIDATION-REDUCTION; PALMITATES; POSITRON-EMISSION TOMOGRAPHY; VENTRICULAR FUNCTION, LEFT;

EID: 28544440715     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1459     Document Type: Article

References (30)

1. Tamaki N, Fujibayashi Y, Magata Y, Yonekura Y, Konishi J. Radionuclide assessment of myocardial fatty acid metabolism by PET and SPECT. J Nucl Cardiol 1995; 2: 256 - 266.
2. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis 1981; 23: 321 - 336.
3. 11C-acetate PET -Evaluation of regional cardiac oxidative metabolism. Nippon Rinsho 1994; 52(Suppl 1): 622 - 628 (in Japanese).
4. Barrett BJ, Schwartz RG, Francis CK, Zaret BL. Regulation by insulin of myocardial glucose and fatty acid metabolism in the conscious dog. J Clin Invest 1984; 74: 1073 - 1079.
5. Ohte N, Kurokawa K, Iida A, Narita H, Akita S, Yajima K, et al. Myocardial oxidative metabolism in remote normal regions in the left ventricles with remodeling after myocardial infarction: Effect of• -adrenoceptor blockers. J Nucl Med 2002; 43: 780 - 785.
6. Grover-McKay M, Schelbert HR, Schwaiger M, Sochor H, Guzy PM, Krivokapich J, et al. Identification of impaired metabolic reserve by atrial pacing in patients with significant coronary artery stenosis. Circulation 1986; 74: 281 - 292.
7. Schelbert HR, Henze E, Sochor H, Grossman RG, Huang SC, Barrio JR, et al. Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. Am Heart J 1986; 111: 1055 - 1064.
8. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Torizuka T, et al. Assessment of myocardial fatty acid metabolism with positron emission tomography at rest and during dobutamine infusion in patients with coronary artery disease. Am Heart J 1993; 125: 702 - 710.
9. Fox KAA, Abendschein DR, Ambos HD, Sobel BE, Bergmann SR. Efflux of metabolized and nonmetabolized fatty acid from canine myocardium: Implications for quantifying myocardial metabolism tomographycally. Circ Res 1985; 57: 232 - 243.
10. 11C-palmitate. Circulation 1981; 64: 689 - 699.
11. Rosamond TL, Abendschein DR, Sobel BE, Bergmann SR, Fox KAA. The metabolic fate of radiolabeled palmitate in ischemic canine myocardium: Implications for positron emission tomography. J Nucl Med 1987; 28: 1322 - 1329.
12. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med 1989; 30: 1489 - 1499.
13. Brown M, Marshall DR, Sobel BE, Bergmann SR. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987; 76: 687 - 696.
14. Brown MA, Myers DW, Bergmann SR. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988; 12: 1054 - 1063.
15. 15O] O2 PET for the assessment of myocardial oxygen utilization in patients with chronic myocardial infarction. Eur J Nucl Med 2001; 28: 334 - 339.
16. 11C-acetate in patients with old myocardial infarction: Usefulness of low-dose dobutamine infusion. Circulation 1996; 94: 1834 - 1841.
17. Krivokapich J, Huang SC, Schelbert HR. Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 1993; 71: 1351 - 1356.
18. Gropler RJ, Siegel BA, Geltman EM. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991; 32: 245 - 251.
19. Chan SY, Brunken RC, Phelps ME, Schelbert HR. Use of the metabolic tracer carbon-11-acetate for evaluation of regional myocardial perfusion. J Nucl Med 1991; 32: 665 - 672.
20. Brown MA, Myears DW, Bergmann SR. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989; 30: 187 - 193.
21. 11C] acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium. Circulation 1990; 81: 1594 - 1605.
22. Buck A, Wolpers HG, Hutchins GD, Savas V, Mangner TJ, Nguyen N, et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 1991; 32: 1950 - 1957.
23. Schön HR, Schelbert HR, Robinson G, Njafi A, Huang SC, Hansen H, et al. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I: Kinetics of C-11 palmitic acid in normal myocardium. Am Heart J 1982; 103: 532 - 547.
24. Schön HR, Schelbert HR, Najafi A, Hansen H, Huang H, Barrio J, et al. C-11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. II: Kinetics of C-11 palmitic acid in acutely ischemic myocardium. Am Heart J 1982; 103: 548 - 561.
25. Lerch RA, Bergmann SR, Ambos HD, Welch MJ, Ter-Pogossian MM, Sobel BE. Effect of flow-independent reduction of metabolism on regional myocardial clearance of 11C-palmitate. Circulation 1982; 65: 731 - 738.
26. 123I-betamethyl-p-iodophenyl-pentadecanoic acid (BMIPP) single photon emission computed tomography (SPECT) in patients with chest pain: Comparison with rest stress 99mTc-tetrofosmin SPECT and coronary angiography. Circ J 2004; 68: 547 - 552.
27. 99mTc-tetrofosmin SPECT imaging: A study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J 2005; 69: 311 - 319.
28. Tani T, Teragaki M, Watanabe H, Muro T, Yamagishi H, Akioka, K, et al. Detecting viable myocardium and predicting functional improvement: Comparison of positron emission tomography, rest redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography. Circ J 2004; 68: 950 - 957.
29. Tamaki N. Role of BMIPP imaging for risk stratification in patients with coronary artery disease. J Nucl Cardiol 2005; 12: 148 - 150.
30. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methylbranched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818 - 1822.